Device Trial Radar · NCT06350864
HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU
Last checked: Nov 20, 2026Latest source record: Oct 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Apr 10, 2024
Primary completion
Sep 1, 2024
Study completion Sep 20, 2024
Sponsor
- Lead sponsor
- Ain Shams UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 5, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 20 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Conventional supplemental oxygen therapy (COT) during upper gastrointestinal (UGI) endoscopy via nasal catheter is considered the standard practice in maintenance of oxygenation and prevention of hypoxia. However, it is still unclear if this oxygen delivery method is optimal in a prolonged (more than 15 minutes) procedure in patients admitted to the ICU. Because of shortage of data in this concern, this prospective, randomized, controlled clinical trial study will aim to evaluate and compare the efficacy of high-flow nasal cannula (HFNC) oxygen therapy versus COT in patients who will undergo prolonged either diagnostic or therapeutic UGI endoscopy in the intensive care unit (ICU) .
Conditions
- Upper Gastrointestinal Bleeding
Interventions
High-flow nasal cannula (HFNC)Device
high flow cartridge and adult size nasal cannula: (flow range: 5-40L/minute, oxygen concentration (FiO2): 21-100%, temperature range: 33-39◦ C, humidity minimum of 12mg/liter)
Conventional nasal oxygen therapy (COT)Device
Adult size, single use nasal cannula
Upper gastrointestinal endoscopy (UGE) including gastroscopyDevice
Upper gastrointestinal endoscopy (UGE) will be either diagnostic and/or therapeutic including variceal band ligation, endoscopic hemostasis as injection of bleeding peptic ulcers with adrenaline or bleeders control via either argon plasma coagulation (APC) or heater probe coagulation.
Upper gastrointestinal endoscopy (UGE) including Endoscopic ultrasound (EUA)Device
Upper gastrointestinal endoscopy (UGE) will be diagnostic
Primary outcomes
What the sponsor says the trial is designed to measure.
- Any occurrence of at least moderate hypoxemia of any duration measured by pulse oximetry during the procedure.Time frame: During the procedure.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ain Shams University-Faculty of Medicine
Cairo, Egypt
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.